POM121C expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.762200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.929200E-01
Normal-vs-Stage2
5.402800E-01
Normal-vs-Stage3
1.462410E-01
Normal-vs-Stage4
9.100200E-01
Stage1-vs-Stage2
4.641800E-01
Stage1-vs-Stage3
1.046790E-01
Stage1-vs-Stage4
7.610000E-01
Stage2-vs-Stage3
1.094260E-02
Stage2-vs-Stage4
3.440600E-01
Stage3-vs-Stage4
3.601600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.791800E-01
Normal-vs-AfricanAmerican
9.184800E-01
Normal-vs-Asian
5.720400E-01
Caucasian-vs-AfricanAmerican
6.916000E-01
Caucasian-vs-Asian
5.333400E-01
AfricanAmerican-vs-Asian
4.848600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.533400E-01
Normal-vs-Female
7.079800E-01
Male-vs-Female
9.727400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.303600E-01
Normal-vs-Age(41-60Yrs)
9.723200E-01
Normal-vs-Age(61-80Yrs)
4.732400E-01
Normal-vs-Age(81-100Yrs)
5.229400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.200000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.263200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.742600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.558200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.577100E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.539600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.479800E-01
Normal-vs-Daily Drinker
3.827200E-01
Normal-vs-Weekly Drinker
8.755000E-01
Normal-vs-Occasional Drinker
9.250000E-01
Normal-vs-Social Drinker
8.445200E-01
Non Drinker-vs-Daily Drinker
9.535000E-01
Non Drinker-vs-Weekly Drinker
2.726000E-01
Non Drinker-vs-Occasional Drinker
1.399030E-01
Non Drinker-vs-Social Drinker
7.698200E-02
Daily Drinker-vs-Weekly Drinker
2.342800E-01
Daily Drinker-vs-Occasional Drinker
1.076970E-01
Daily Drinker-vs-Social Drinker
1.115990E-01
Weekly Drinker-vs-Occasional Drinker
8.645200E-01
Weekly Drinker-vs-Social Drinker
5.315400E-01
Occasional Drinker-vs-Social Drinker
5.570000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.757790E-01
Normal-vs-Grade 2
6.015900E-03
Normal-vs-Grade 3
1.099690E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.083000E-01
Grade 1-vs-Grade 3
5.839600E-01
Grade 1-vs-Grade 4
1.757790E-01
Grade 2-vs-Grade 3
2.604400E-01
Grade 2-vs-Grade 4
6.015900E-03
Grade 3-vs-Grade 4
1.099690E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.572200E-01
Normal-vs-NonDiabetic
7.355400E-01
Diabetic-vs-NonDiabetic
4.842200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.096800E-01
Normal-vs-NoPancreatitis
6.729800E-01
Pancreatitis-vs-NoPancreatitis
5.655000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.156800E-01
Normal-vs-N1
5.484800E-01
N0-vs-N1
7.768600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.548000E-01
Normal-vs-TP53-NonMutant
8.428800E-01
TP53-Mutant-vs-TP53-NonMutant
1.521520E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
